Corvus Pharmaceuticals
CRVS
#6513
Rank
A$1.23 B
Marketcap
A$14.61
Share price
-3.40%
Change (1 day)
10.10%
Change (1 year)

EPS for Corvus Pharmaceuticals (CRVS)

EPS in 2026 (TTM): A-$0.90

According to Corvus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$0.92. In 2025 the company made an earnings per share (EPS) of A-$0.24 an increase over its 2024 EPS that were of A-$1.47.

EPS history for Corvus Pharmaceuticals from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.90271.1%
2025A-$0.24-83.51%
2024A-$1.47
2022A-$1.34-16.04%
2021A-$1.60404.76%
2020A-$0.32-86.79%
2019A-$2.40-9.14%
2018A-$2.64-35.66%
2017A-$4.11-60.47%
2016A-$10.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.04 121.31%๐Ÿ‡บ๐Ÿ‡ธ USA